|
⚲
|
| Keyboard |
| Diadema Partners LP
✚
|
|
|---|---|
| CRD # | 331527 |
| SEC # | 801-130477 |
| CIK # | 0002026172 |
| AUM | 397.9 M (2026-03-20) |
| Employees | 6 (67% Investors, 0% Brokers) |
| Phone | 646-979-8432 |
| Address | 2140 Headquarters Plaza Morristown, NJ 07960 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002026172 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| United Therapeutics Corp | 51.9 | ||
| Vertex Pharmaceuticals Inc / Ma | 43.3 | ||
| Viking Therapeutics Inc | 38.5 | ||
| Nile Therapeutics Inc | 31.4 | ||
| Abivax Sa | 30.5 | ||
| Liquidia Corp | 26.9 | ||
| Revolution Medicines Inc | 20.1 | ||
| Apogee Therapeutics Inc | 18.7 | ||
| Incyte Corp | 17.3 | ||
| Kodiak Sciences Inc | 16.8 | ||
| Cytokinetics Inc | 16.5 | ||
| Johnson & Johnson | 13.1 | ||
| UNUM Therapeutics Inc | 12.4 | ||
| Merck & Co Inc | 12.0 | ||
| Jazz Pharmaceuticals Inc | 10.4 | ||
| Structure Therapeutics Inc | 9.6 | ||
| Uniqure NV | 9.5 | ||
| Roivant Sciences Ltd | 9.3 | ||
| BioMarin Pharmaceutical Inc | 8.4 | ||
| Moderna Inc | 8.1 | ||
| Manhattan Pharmaceuticals Inc | 6.9 | ||
| Corcept Therapeutics Inc | 6.8 | ||
| Edgewise Therapeutics Inc | 6.7 | ||
| Bridgebio Pharma Inc | 6.3 | ||
| Replimune Group Inc | 5.9 | ||
| Immunocore Holdings PLC | 5.8 | ||
| Lilly Eli & Co | 5.5 | ||
| AbbVie Inc | 5.2 | ||
| Corbus Pharmaceuticals Holdings Inc | 5.2 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Persistent Asset Global Select Fund SPC - Persistent Asset X Segregated Portfolio | 2025-03-26 | 110.5 M | |
| HF | Diadema Partners Master Fund LP | [2024-10-11] | 5.2 M | 117.3 M |
| Filed 2025-06-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Diadema Strategic Fund LP | [2024-10-11] | 25.0 M | 109.9 M |
| Filed 2025-06-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 363.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 34.1 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 397.9 |
| By Discretionary | ||
| Discretionary | 7 | 397.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 397.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 288.0 | |
| United States Persons | 109.9 | |
| Total | 7 | 397.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Diadema Partners LP | Promoter | 3 | 2 | |
| Timothy Bassett | Executive Officer | 3 | 2 | |
| Diadema Partners Fund GP LLC | Executive Officer | 2 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002026172] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 254900Q7N24OH37IJP22 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Charter Oak Advisors LP
✚
|
NY | 403.9 M |
|
Palo Duro Investment Partners LP
✚
|
IL | 402.8 M |
|
Balch Hill Capital LLC
✚
|
402.1 M | |
|
O'Neil Global Advisors Inc
✚
|
CA | 401.9 M |
|
Ratan Capital Management LP
✚
|
FL | 401.9 M |
|
Numerixs Investment Technologies Inc
✚
|
DE | 400.0 M |
|
Bayard Asset Management LLC
✚
|
NJ | 397.3 M |
|
Anabranch Capital Management LP
✚
|
CT | 397.0 M |
|
The Visualize Group LP
✚
|
NY | 396.1 M |
|
India Capital Management Limited
✚
|
395.3 M |